OVERACTIVE BLADDER PATIENTS ≥65 YEARS OF AGE HAVE A SIMILAR EFFICACY AND SAFETY PROFILE WITH ONABOTULINUMTOXINA AS PATIENTS < 65 YEARS OF AGE

被引：1
|
作者：
Moore, Courtenay
Kaufmann, Albert
Joshi, Manher
Nardo, Christopher
Zheng, Yan
Herschorn, Sender
机构：
来源：
JOURNAL OF UROLOGY | 2014年 / 191卷 / 04期
关键词：
D O I：
10.1016/j.juro.2014.02.2405
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP76-12
引用
收藏
页码：E886 / E886
页数：1
相关论文
共 50 条
  • [1] ONABOTULINUMTOXINA HAS A POSITIVE SAFETY AND EFFICACY PROFILE IN OVERACTIVE BLADDER (OAB) PATIENTS <65 AND ≥65 YEARS OF AGE
    Moore, Courtenay
    Kaufmann, Albert
    Joshi, Manher
    Zheng, Yan
    Herschorn, Sender
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S91 - S91
  • [2] Comparison of efficacy and safety assessment of Fluvastatin in patients <65 years versus ≥65 years of age
    Bruckert, E
    Verpilleux, MP
    Dejager, S
    Isaacsohn, J
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (08): : 1142 - 1148
  • [3] Safety and Efficacy of Oxybutynin Chloride Topical Gel (OTG) for Treatment of Overactive Bladder (OAB) in Patients Aged <65 and ≥65 Years
    Zinner, N. R.
    Caramelli, K. E.
    Thomas, H.
    Hoel, G. E.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 : S25 - S26
  • [4] Trospium chloride improves symptoms in overactive bladder patients over the age of 65 years.
    Zinner, N
    Staskin, D
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S77 - S77
  • [5] The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
    Jackson, Robert L.
    Hunt, Barbara
    MacDonald, Patricia A.
    BMC GERIATRICS, 2012, 12
  • [6] The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
    Robert L Jackson
    Barbara Hunt
    Patricia A MacDonald
    BMC Geriatrics, 12
  • [7] Mobilization in patients over 65 years of age and patients between 55 to 65 years of age is similar in terms of safety and success in Multiple Myeloma and lymphoma patients: A Single Center Experience
    Cekdemir, D.
    Atesoglu, E. Birtas
    Bai, C.
    Dora, I.
    Kosan, B.
    Er, E.
    Baskan, N.
    Saritas, B.
    Kural, S.
    Gucyener, E.
    Sengezer, M.
    Tiryaki, N.
    Gulbas, Z.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S130 - S131
  • [8] Similar Efficacy and Safety of Basaglar® and Lantus® in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study
    Pollom, Robyn K.
    Costigan, Timothy
    Lacaya, Lyndon B.
    Ilag, Liza L.
    Hollander, Priscilla A.
    DIABETES THERAPY, 2018, 9 (02) : 827 - 837
  • [9] Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years
    Boustani, M. A.
    Pittman, I.
    Yu, M.
    Thieu, V. T.
    Varnado, O. J.
    Juneja, R.
    DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 820 - 828
  • [10] Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age
    John Tesser
    Shelly Kafka
    Raphael J. DeHoratius
    Stephen Xu
    Elizabeth C. Hsia
    Anthony Turkiewicz
    Arthritis Research & Therapy, 21
12345